Hemoglobin and Iron Metabolism Practice Questions

Q: Hb - Barts is?

αo γ4. **Explanation:** **Hb-Barts** is a pathological hemoglobin variant associated with **Alpha-Thalassemia**. 1. **Why Option C is correct:** In Alpha-thalassemia, there is a deficiency or total absence of alpha ($\alpha$) globin chain synthesis. During fetal life, the primary hemoglobin is HbF ($\alpha_2\gamma_2$). When $\alpha$-chains are unavailable (specifically in the most severe form, **Hydrops Fetalis**, where all 4 alpha genes are deleted), the excess, unpaired gamma ($\gamma$) chains tetramerize to form **$\gamma_4$**, known as **Hb-Barts**. Because it lacks $\alpha$-chains, it is denoted as $\alpha^0\gamma_4$. 2. **Analysis of Incorrect Options:** * **Option A ($\alpha_2\beta_2$):** This represents **HbA** (Normal Adult Hemoglobin). * **Option B ($\alpha^0\beta_4$):** This represents **HbH**. It occurs when there is a deficiency of $\alpha$-chains in adults, leading to the tetramerization of excess beta ($\beta$) chains. * **Option D ($\alpha_2\gamma_2$):** This represents **HbF** (Normal Fetal Hemoglobin). **High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Affinity:** Hb-Barts has an extremely high affinity for oxygen (it does not release $O_2$ to tissues), making it physiologically useless and resulting in intrauterine death (Hydrops Fetalis). * **HbH Disease:** Caused by a 3-gene deletion ($--/-\alpha$). It presents with "Golf ball-like" inclusions on Supravital staining (Brilliant Cresyl Blue). * **Electrophoresis:** On alkaline electrophoresis, Hb-Barts is the fastest-moving hemoglobin (migrates further than HbA and HbH). * **Alpha-Thalassemia Trait:** 2-gene deletion; **Silent Carrier:** 1-gene deletion.

Q: Ferrochelatase is inhibited by which of the following?

Lead. ### Explanation **Correct Option: B (Lead)** **Mechanism of Action:** Ferrochelatase is the final enzyme in the heme synthesis pathway, located in the mitochondria. It catalyzes the insertion of ferrous iron ($Fe^{2+}$) into Protoporphyrin IX to form Heme. Lead ($Pb$) is a potent inhibitor of this enzyme because it competes with iron for the binding site. Additionally, lead inhibits **$\delta$-aminolevulinic acid dehydratase (ALAD)**. The inhibition of these two enzymes leads to the accumulation of Protoporphyrin IX and $\delta$-ALA, which are hallmark biochemical findings in lead poisoning. **Analysis of Incorrect Options:** * **A. Arsenic:** Arsenic primarily inhibits enzymes requiring **Lipoic acid** as a cofactor, such as the Pyruvate Dehydrogenase (PDH) complex and $\alpha$-ketoglutarate dehydrogenase, by binding to sulfhydryl groups. * **C. Chromium:** While hexavalent chromium is toxic and carcinogenic, it does not specifically target the heme synthesis pathway or ferrochelatase. * **D. Mercury:** Mercury binds to various sulfhydryl-containing enzymes and proteins, causing systemic toxicity (especially neurological and renal), but it is not the classic inhibitor associated with ferrochelatase in medical curricula. **High-Yield Clinical Pearls for NEET-PG:** * **Microcytic Hypochromic Anemia:** Lead poisoning causes anemia due to decreased heme synthesis. * **Basophilic Stippling:** A classic peripheral smear finding in lead poisoning due to the inhibition of pyrimidine 5'-nucleotidase, leading to RNA degradation products. * **Diagnostic Markers:** Elevated **Zinc Protoporphyrin (ZPP)** levels are seen because zinc is incorporated into the porphyrin ring when iron cannot be used. * **Clinical Presentation:** Look for "Burton’s lines" (bluish-purple gingival margin), colicky abdominal pain, and wrist/foot drop in adults.

Q: A defect in the MRP2 gene results in which hereditary disorder of bilirubin metabolism?

Dubin-Johnson syndrome. **Explanation:** The correct answer is **Dubin-Johnson syndrome**. This condition is an autosomal recessive disorder caused by a mutation in the **ABCC2 gene**, which encodes the **Multidrug Resistance-associated Protein 2 (MRP2)**. MRP2 is an ATP-dependent canalicular transporter responsible for the efflux of conjugated bilirubin from hepatocytes into the bile canaliculi. A defect in this protein leads to the accumulation of conjugated bilirubin within the liver cells, which then leaks back into the blood, causing **conjugated (direct) hyperbilirubinemia**. **Why the other options are incorrect:** * **Gilbert syndrome:** Caused by a mutation in the promoter region of the **UGT1A1 gene**, leading to reduced activity (approx. 30%) of the enzyme UDP-glucuronosyltransferase. It results in mild *unconjugated* hyperbilirubinemia. * **Crigler-Najjar syndrome type I:** Characterized by a **complete absence** of UGT1A1 enzyme activity. It causes severe, life-threatening *unconjugated* hyperbilirubinemia. * **Crigler-Najjar syndrome type II (Arias syndrome):** Characterized by a **marked reduction** (less than 10%) in UGT1A1 activity. It results in moderate *unconjugated* hyperbilirubinemia and usually responds to Phenobarbital. **High-Yield Clinical Pearls for NEET-PG:** * **Black Liver:** A hallmark of Dubin-Johnson syndrome is a grossly **black/darkly pigmented liver** due to the accumulation of epinephrine metabolites (melanin-like pigment) in lysosomes. * **Urinary Coproporphyrins:** In Dubin-Johnson, the *total* urinary coproporphyrin levels are normal, but **>80% is Coproporphyrin I** (normally, Coproporphyrin III predominates). * **Rotor Syndrome:** Often confused with Dubin-Johnson, but it lacks liver pigmentation and is caused by defects in OATP1B1 and OATP1B3 transporters.

Q: Which of the following is NOT a site of heme synthesis?

Red blood cells. ### Explanation The synthesis of heme is a complex metabolic pathway that occurs partly in the **mitochondria** and partly in the **cytosol**. **1. Why Red Blood Cells (RBCs) are the correct answer:** Mature red blood cells lack **mitochondria** and a **nucleus**. Since the first step (catalyzed by ALA synthase) and the final steps (catalyzed by ferrochelatase) of heme synthesis must occur within the mitochondria, mature RBCs are incapable of synthesizing heme. While they are filled with hemoglobin, that hemoglobin was synthesized during the earlier erythroblast stages of development. **2. Analysis of Incorrect Options:** * **Hepatocytes (Liver):** The liver is the second most active site of heme synthesis (accounting for ~15%). Heme here is primarily used for **Cytochrome P450** enzymes involved in drug detoxification. * **Bone Marrow (Erythroid precursor cells):** This is the primary site of heme synthesis (~85%). Proerythroblasts and erythroblasts contain the necessary organelles (mitochondria) to produce heme for hemoglobin production. * **Osteocytes:** While not a primary site like the liver or marrow, almost all nucleated cells containing mitochondria (including osteocytes) possess the enzymatic machinery to produce small amounts of heme for essential hemoproteins like cytochromes in the electron transport chain. **3. NEET-PG High-Yield Pearls:** * **Rate-limiting enzyme:** ALA Synthase (ALAS-1 in liver, ALAS-2 in erythroid tissue). * **Substrates:** Glycine + Succinyl CoA. * **Lead Poisoning:** Inhibits **ALA Dehydratase** and **Ferrochelatase**, leading to anemia and stippled RBCs. * **Vitamin Link:** Pyridoxal phosphate (Vitamin B6) is a mandatory cofactor for ALA synthase; its deficiency can lead to **Sideroblastic Anemia**.

Q: What is the primary storage form of iron in the body?

Ferritin. **Explanation:** **1. Why Ferritin is Correct:** Iron is highly reactive and can generate toxic free radicals via the Fenton reaction. To prevent this, the body stores iron in a non-toxic, water-soluble protein complex called **Ferritin**. It is found in almost all cells, but primarily in the liver (hepatocytes), spleen, and bone marrow. A small amount circulates in the serum, which serves as a clinical marker for total body iron stores. While **hemosiderin** is another storage form (insoluble and found in iron overload), ferritin remains the **primary** and most readily available storage form. **2. Why Other Options are Incorrect:** * **Transferrin:** This is the primary **transport** protein for iron in the blood. It carries iron from the site of absorption or recycling to the bone marrow for erythropoiesis. * **Hepcidin:** This is the **master regulator** of iron homeostasis. It is a hormone produced by the liver that inhibits iron absorption in the gut and iron release from macrophages by degrading ferroportin. * **Ferroportin:** This is the only known **exporter** of iron from cells (enterocytes and macrophages) into the plasma. **3. High-Yield Clinical Pearls for NEET-PG:** * **Serum Ferritin:** The most sensitive and specific lab test for diagnosing **Iron Deficiency Anemia (IDA)** (levels <15 ng/mL). * **Acute Phase Reactant:** Ferritin levels rise during inflammation, infection, or malignancy, which can mask an underlying iron deficiency. * **Prussian Blue Stain:** Used to visualize iron stores (hemosiderin) in bone marrow aspirates. * **Total Iron Binding Capacity (TIBC):** An indirect measure of transferrin levels; it increases in IDA and decreases in iron overload.

Q: Heme is converted to bilirubin mainly in which organ?

Spleen. ### Explanation **Correct Option: C. Spleen** The degradation of heme occurs within the **Reticuloendothelial System (RES)**, also known as the Mononuclear Phagocyte System. Senescent (old) erythrocytes are primarily trapped and destroyed in the **spleen**, which acts as the "graveyard of RBCs." Inside splenic macrophages, the enzyme **Heme Oxygenase** breaks down heme into biliverdin, releasing iron and carbon monoxide. Subsequently, **Biliverdin Reductase** converts biliverdin into unconjugated bilirubin. While the RES in the liver and bone marrow also participates, the spleen is the primary anatomical site for this physiological process. **Why other options are incorrect:** * **A. Kidney:** The kidney does not metabolize heme. It is responsible for excreting water-soluble urobilin (which gives urine its yellow color) but does not produce bilirubin. * **B. Liver:** This is a common point of confusion. The liver is responsible for the **conjugation** of bilirubin (via UDP-glucuronosyltransferase) and its excretion into bile, but the initial conversion of heme to bilirubin occurs predominantly in the spleen. * **D. Bone Marrow:** While the bone marrow contains RES cells that can degrade heme (especially in cases of ineffective erythropoiesis), it is not the *main* site for the physiological turnover of aged RBCs. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** Heme Oxygenase is the rate-limiting enzyme in bilirubin synthesis. * **Only source of CO:** The conversion of heme to biliverdin is the only endogenous reaction in the human body that produces **Carbon Monoxide (CO)**. * **Van den Bergh Reaction:** Unconjugated bilirubin (produced in the spleen) gives an **indirect** reaction, while conjugated bilirubin (produced in the liver) gives a **direct** reaction. * **Transport:** Unconjugated bilirubin is water-insoluble and must be transported to the liver bound to **albumin**.

Q: Which vitamin is required for the rate-limiting step of heme synthesis?

Vitamin B6. ### Explanation **Correct Option: D (Vitamin B6)** The rate-limiting step of heme synthesis is the condensation of **Succinyl CoA** and **Glycine** to form **$\delta$-Aminolevulinic acid (ALA)**. This reaction is catalyzed by the enzyme **ALA Synthase (ALAS)**, which is located in the mitochondria. **Pyridoxal Phosphate (PLP)**, the active form of **Vitamin B6**, serves as an essential co-factor for ALA Synthase. It facilitates the decarboxylation of glycine, allowing the reaction to proceed. Without Vitamin B6, heme production is impaired, leading to **Sideroblastic Anemia**, where iron accumulates in the mitochondria of erythroid precursors (forming "ringed sideroblasts") because it cannot be incorporated into heme. --- ### Analysis of Incorrect Options * **A. Vitamin B1 (Thiamine):** Acts as a co-factor for oxidative decarboxylation reactions (e.g., Pyruvate Dehydrogenase, $\alpha$-Ketoglutarate Dehydrogenase) and Transketolase. It is not involved in heme synthesis. * **B. Vitamin B2 (Riboflavin):** Precursor for FMN and FAD, which are involved in redox reactions (e.g., Succinate Dehydrogenase). * **C. Vitamin B3 (Niacin):** Precursor for NAD and NADP, primarily involved in electron transport and various metabolic pathways, but not the ALAS reaction. --- ### High-Yield Clinical Pearls for NEET-PG * **Rate-limiting enzyme:** ALA Synthase (ALAS-1 in liver; ALAS-2 in erythroid tissue). * **Inhibitors:** Hemin and Glucose inhibit ALAS-1 (relevant in managing Porphyrias). * **Drug-induced Anemia:** **Isoniazid (INH)**, used in TB treatment, inhibits Pyridoxine kinase. This leads to Vitamin B6 deficiency and subsequent Sideroblastic Anemia. * **Lead Poisoning:** Inhibits **ALA Dehydratase** and **Ferrochelatase**, but *not* the rate-limiting ALA Synthase.

Q: Which of the following statements is TRUE about the iron-responsive element (IRE)?

It forms a stem-loop structure in messenger RNA.. **Explanation:** The **Iron-Responsive Element (IRE)** is a specific, non-coding sequence of nucleotides that forms a characteristic **stem-loop (hairpin) structure** in the untranslated regions (UTRs) of certain messenger RNAs (mRNAs). This mechanism allows the cell to regulate iron homeostasis at the post-transcriptional level through the action of **Iron Regulatory Proteins (IRPs)**. **Why Option A is correct:** The IRE is defined by its secondary structure—a stem-loop. When iron levels are low, IRPs bind to these loops. Depending on the location of the loop (5' or 3' UTR), this binding either inhibits translation or stabilizes the mRNA. **Analysis of Incorrect Options:** * **Option B:** In **Transferrin Receptor (TfR) mRNA**, the IREs are located in the **3' UTR**. Binding of IRP here stabilizes the mRNA, preventing its degradation and increasing receptor synthesis to bring more iron into the cell. * **Option C:** In **Ferritin mRNA**, the IRE is located in the **5' UTR**. Binding of IRP here acts as a physical block to the ribosome, inhibiting translation to prevent excess iron storage when iron is scarce. * **Option D:** The IRP does not degrade the IRE. Instead, it protects the mRNA from **ribonucleases** (in the case of TfR) or blocks the **initiation complex** (in the case of Ferritin). **High-Yield Clinical Pearls for NEET-PG:** * **High Iron Levels:** Iron binds to IRP, causing it to detach from the mRNA. This leads to **increased Ferritin** synthesis (storage) and **decreased Transferrin Receptor** synthesis (reduced uptake). * **Aconitase Connection:** IRP-1 is bifunctional; when iron is abundant, it functions as the enzyme **c-aconitase** in the cytosol. * **Mnemonic:** **F**erritin = **F**ive prime (5') UTR; **T**ransferrin Receptor = **T**hree prime (3') UTR.

Question 1

Hb - Barts is?

Accepted Answer

αo γ4

Answer

α2 β2

Answer

αo β4

Answer

α2 γ2

Question 2

Ferrochelatase is inhibited by which of the following?

Accepted Answer

Lead

Answer

Arsenic

Answer

Chromium

Answer

Mercury

Question 3

A defect in the MRP2 gene results in which hereditary disorder of bilirubin metabolism?

Accepted Answer

Dubin-Johnson syndrome

Answer

Gilbert syndrome

Answer

Crigler-Najjar syndrome type I

Answer

Crigler-Najjar syndrome type II

Question 4

Which of the following is NOT a site of heme synthesis?

Accepted Answer

Red blood cells

Answer

Hepatocytes

Answer

Osteocytes

Answer

Bone marrow

Question 5

What is the primary storage form of iron in the body?

Accepted Answer

Ferritin

Answer

Transferrin

Answer

Hepcidin

Answer

Ferroportin

Question 6

Heme is converted to bilirubin mainly in which organ?

Accepted Answer

Spleen

Answer

Kidney

Answer

Liver

Answer

Bone marrow

Question 7

Which vitamin is required for the rate-limiting step of heme synthesis?

Accepted Answer

Vitamin B6

Answer

Vitamin B1

Answer

Vitamin B2

Answer

Vitamin B3

Question 8

Iron absorption primarily occurs in which part of the small intestine?

Accepted Answer

Duodenum

Answer

Jejunum

Answer

Ileum

Answer

Colon

Question 9

All the statements about lactoferrin are true, EXCEPT:

Accepted Answer

It transports iron for erythropoiesis

Answer

It has great affinity for iron

Answer

It is present in exocrine secretions of the body

Answer

It is present in secondary granules of neutrophils

Question 10

Which of the following statements is TRUE about the iron-responsive element (IRE)?

Accepted Answer

It forms a stem-loop structure in messenger RNA.

Answer

It is located in the 5' untranslated region (UTR) of transferrin mRNA.

Answer

It is located in the 3' untranslated region (UTR) of ferritin mRNA.

Answer

The IRE-binding protein causes the degradation of the IRE.

Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?